chrX-74529484-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006517.5(SLC16A2):c.1399+43T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.576 in 110,541 control chromosomes in the GnomAD database, including 16,119 homozygotes. There are 18,552 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.58 ( 16119 hom., 18552 hem., cov: 22)
Exomes 𝑓: 0.75 ( 199128 hom. 204718 hem. )
Failed GnomAD Quality Control
Consequence
SLC16A2
NM_006517.5 intron
NM_006517.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0840
Publications
12 publications found
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
SLC16A2 Gene-Disease associations (from GenCC):
- Allan-Herndon-Dudley syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant X-74529484-T-G is Benign according to our data. Variant chrX-74529484-T-G is described in ClinVar as Benign. ClinVar VariationId is 159903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC16A2 | NM_006517.5 | c.1399+43T>G | intron_variant | Intron 5 of 5 | ENST00000587091.6 | NP_006508.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC16A2 | ENST00000587091.6 | c.1399+43T>G | intron_variant | Intron 5 of 5 | 1 | NM_006517.5 | ENSP00000465734.1 | |||
| SLC16A2 | ENST00000590447.1 | c.610-1849T>G | intron_variant | Intron 3 of 3 | 5 | ENSP00000466213.1 | ||||
| SLC16A2 | ENST00000636771.1 | n.*1100+43T>G | intron_variant | Intron 6 of 6 | 5 | ENSP00000490445.1 |
Frequencies
GnomAD3 genomes AF: 0.576 AC: 63643AN: 110491Hom.: 16133 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
63643
AN:
110491
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.606 AC: 63477AN: 104815 AF XY: 0.616 show subpopulations
GnomAD2 exomes
AF:
AC:
63477
AN:
104815
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.754 AC: 705707AN: 935708Hom.: 199128 Cov.: 16 AF XY: 0.760 AC XY: 204718AN XY: 269428 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
705707
AN:
935708
Hom.:
Cov.:
16
AF XY:
AC XY:
204718
AN XY:
269428
show subpopulations
African (AFR)
AF:
AC:
4658
AN:
21951
American (AMR)
AF:
AC:
13032
AN:
27249
Ashkenazi Jewish (ASJ)
AF:
AC:
13860
AN:
17755
East Asian (EAS)
AF:
AC:
548
AN:
26388
South Asian (SAS)
AF:
AC:
23412
AN:
46517
European-Finnish (FIN)
AF:
AC:
26028
AN:
33598
Middle Eastern (MID)
AF:
AC:
2201
AN:
2857
European-Non Finnish (NFE)
AF:
AC:
593737
AN:
718952
Other (OTH)
AF:
AC:
28231
AN:
40441
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
5541
11083
16624
22166
27707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
15424
30848
46272
61696
77120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.576 AC: 63643AN: 110541Hom.: 16119 Cov.: 22 AF XY: 0.565 AC XY: 18552AN XY: 32807 show subpopulations
GnomAD4 genome
AF:
AC:
63643
AN:
110541
Hom.:
Cov.:
22
AF XY:
AC XY:
18552
AN XY:
32807
show subpopulations
African (AFR)
AF:
AC:
6452
AN:
30515
American (AMR)
AF:
AC:
5342
AN:
10385
Ashkenazi Jewish (ASJ)
AF:
AC:
2040
AN:
2618
East Asian (EAS)
AF:
AC:
117
AN:
3521
South Asian (SAS)
AF:
AC:
1181
AN:
2630
European-Finnish (FIN)
AF:
AC:
4471
AN:
5764
Middle Eastern (MID)
AF:
AC:
155
AN:
215
European-Non Finnish (NFE)
AF:
AC:
42393
AN:
52716
Other (OTH)
AF:
AC:
901
AN:
1500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
678
1356
2035
2713
3391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Allan-Herndon-Dudley syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.